Total synthesis and biological evaluation of Amaryllidaceae alkaloids: Narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivatives: Journal of Organic Chemistry

T. Hudlicky, U. Rinner, David Gonzalez, H. Akgun, S. Schilling, P. Siengalewicz, T.A. Martinot, G.R. Pettit

Research output: Contribution to journalArticlepeer-review

Abstract

Biocatalytic approaches have yielded efficient total syntheses of the major Amaryllidaceae alkaloids, all based on the key enzymatic dioxygenation of suitable aromatic precursors. This paper discusses the logic of general synthetic design for lycoricidine, narciclasine, pancratistatin, and 7-deoxypancratistatin. Experimental details are provided for the recently accomplished syntheses of narciclasine, ent-7-deoxypancratistatin, and 10b-epi-deoxypancratistatin via a new and selective opening of a cyclic sulfate over aziridines followed by aza-Payne rearrangement. The structural core of 7-deoxypancratistatin has also been degraded to a series of intermediates in which the amino inositol unit is cleaved and deoxygenated in a homologous fashion. These truncated derivatives and the compounds from the synthesis of the unnatural derivatives have been tested against six important human cancer cell lines in an effort to further develop the understanding of the mode of action for the most active congener in this group, pancratistatin. The results of the biological activity testing as well as experimental, spectral, and analytical data are provided in this manuscript for all relevant compounds.
Original languageEnglish
Pages (from-to)8726-8743
Number of pages18
JournalJ. Org. Chem.
Volume67
Issue number25
DOIs
Publication statusPublished - 26 Jul 2002
Externally publishedYes

Keywords

  • Alkaloids
  • Amaryllidaceae Alkaloids
  • Angiosperms
  • Animals
  • Antineoplastic Agents, Phytogenic
  • Catalysis
  • Cyclization
  • Drug Screening Assays, Antitumor
  • Humans
  • Isoquinolines
  • Leukemia P388
  • Mice
  • Molecular Structure
  • Nuclear Magnetic Resonance, Biomolecular
  • Phenanthridines
  • Plants, Medicinal
  • Stereoisomerism
  • Structure-Activity Relationship
  • Tumor Cells, Cultured
  • Biocatalysts
  • Cells
  • Derivatives
  • Enzymes
  • Synthesis (chemical)
  • 10b epi deoxypancratistatin
  • 7 deoxypancratistatin
  • alkaloid
  • aziridine derivative
  • ent 7 deoxypancratistatin
  • narciclasine
  • unclassified drug
  • 10b-epi-deoxypancratistatin
  • 7-deoxypancratistatin
  • Amaryllidaceae alkaloid
  • antineoplastic agent
  • isoquinoline derivative
  • lycorine
  • pancratistatin
  • phenanthridine derivative
  • article
  • cancer cell culture
  • drug activity
  • drug mechanism
  • drug structure
  • drug synthesis
  • angiosperm
  • animal
  • catalysis
  • cell culture
  • chemical structure
  • chemistry
  • cyclization
  • drug effect
  • drug screening
  • human
  • leukemia P 388
  • medicinal plant
  • mouse
  • nuclear magnetic resonance
  • stereoisomerism
  • structure activity relation
  • synthesis
  • Organic compounds

Research fields

  • Total Synthesis
  • Alkaloids
  • Amaryllidaceae alkaloids

IMC Research Focuses

  • Materials science

ÖFOS 2012 - Austrian Fields of Study

  • 104015 Organic chemistry

Fingerprint

Dive into the research topics of 'Total synthesis and biological evaluation of Amaryllidaceae alkaloids: Narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivatives: Journal of Organic Chemistry'. Together they form a unique fingerprint.

Cite this